Should You Buy Eli Lilly Stock After Another Major Win?

It was a buy even before this development."Winners keep winning." Whatever one thinks of this adage, it certainly seems to apply to Eli Lilly (LLY -0.60%). The pharmaceutical giant has been on a tear, racking up important clinical and regulatory victories in the past few years. The result: Eli Lilly has soundly crushed the market in the past five years, and the company is at it again. A recent regulatory win further improved Eli Lilly's prospects. Let's take a closer look.Eli Lilly succeeds where many other ...